Abstract
Toxoplasma gondii is an obligate intracellular parasite of rodents and humans. Interferon-inducible guanylate binding proteins (GBPs) are mediators of T. gondii clearance, however, this mechanism is incomplete. Here, using automated spatially targeted optical micro proteomics we demonstrate that inducible nitric oxide synthetase (iNOS) is highly enriched at GBP2+ parasitophorous vacuoles (PV) in murine macrophages. iNOS expression in macrophages is necessary to limit T. gondii load in vivo and in vitro. Although iNOS activity is dispensable for GBP2 recruitment and PV membrane ruffling; parasites can replicate, egress and shed GBP2 when iNOS is inhibited. T. gondii clearance by iNOS requires nitric oxide, leading to nitration of the PV and collapse of the intravacuolar network of membranes in a chromosome 3 GBP-dependent manner. We conclude that reactive nitrogen species generated by iNOS cooperate with GBPs to target distinct structures in the PV that are necessary for optimal parasite clearance in macrophages.
Similar content being viewed by others
Introduction
Toxoplasma gondii is an obligate intracellular parasite with a remarkably broad intermediate host range that includes humans and mice. Although T. gondii infects approximately one-third of the human population, the infection is often asymptomatic1. Severe complications emerge in immuno-compromised individuals or during infection of the fetus, underscoring the importance of a functional immune response to control T. gondii infection2.
The parasite’s ability to infect and grow within most nucleated cell types in hundreds of host species is related to the formation and maintenance of the parasitophorous vacuole (PV). The PV membrane (PVM) is formed from the host plasma membrane during T. gondii invasion and connected to the parasite by an intra-vacuolar network (IVN) of host-derived lipid nano-tubes3. The parasite uses secreted effectors to maintain the PVM and the IVN membranes, recruit nutrients to the vacuole, and evade immune recognition4. Formation of the PV facilitates evasion from Toll-like receptors (TLR) 7, −8, −95,6 and −11 (TLR11 is a pseudogene in humans), which recognize phagocytosed, damaged parasites (Fig. 1a)7. Disruption of the gut epithelium during oral infection leads to TLR2, −4, and −9 signaling in response to commensal microbiota5,8,9. TLR signaling through NF-κB produces interleukin 12 (IL-12), which is critical for IFNγ production7,10,11. IFNγ is necessary for both the protective CD8 T cell response and for cell-autonomous control of parasite growth in human and murine cells12.
IFNγ receptor signaling through STAT1 transcriptionally upregulates interferon-inducible GTPases (IIGs) which survey cells for damaged or non-self-membranes and target them for removal (Fig. 1a)13,14,15. In mice, the p47 immunity-related GTPases (IRG)16, Irgb617, Irga618 are recruited to the PVM19,20, under the regulatory control of IRGM1, −2 and −316,21,22,23. In addition, the p65 small guanylate-binding proteins (GBPs) encoded on chromosome 3 (GBP1–3, 5, and 7)24 and chromosome 5 (GBPs 6, 9)25,26 are recruited to PVM and play partially redundant roles in vacuole disruption and parasite clearance in cell culture and in vivo24,27,28,29. Live imaging studies have shown that IRGb6 recruitment to the PV is followed by the re-localization of fluorescent proteins from the host cytosol to the parasite then parasite rounding (a measure of death)19. Mouse IRGb617, GBP127 and chromosome 3 GBPs24 are associated with PVM ‘ruffling’ and discontinuity by transmission electron microscopy. Human GBP1 (the homolog of mouse GBP2) positive vacuoles are associated with permeability to cytosolic dye and leakage of parasite nucleic acids to the cytosol compared to GBP1-negative vacuoles30. These data indicate that IIGs are necessary for vacuole targeting and permeability; however, they have not been shown to be sufficient for T. gondii killing, indicating that there are gaps in the mechanistic understanding of this process.
Heterogeneous IIG targeting to the PV has been a major challenge to understanding the mechanism of cell-autonomous T. gondii clearance. The frequency of IIG-positive vacuoles ranges from 30–60% of all PV depending on the identity of the IIG, host and parasite cell type24,25,27,28,30. Tools to isolate the PV are limited. Subcellular fractionation does not preserve the intact PVM31. A proximity biotinylation tool to study the PV proteome has been developed, however, it cannot differentiate between IIG-targeted and IIG-negative vacuoles in the population32. An additional hurdle is that IRG and GBP activity is also spatially regulated. A single host cell contains both inactive pools of the GTPases localized to vesicles, Golgi, or ER and active GTPase pools targeted to pathogen-associated membranes or damaged-self membranes14,15.
Here, we leverage the heterogeneity in IIG recruitment to the PV for comparative proteomics using automated spatially targeted optical micro-proteomics (autoSTOMP)33,34,35. This led to the discovery that iNOS expression in murine macrophages and dendritic cells is necessary for efficient parasite clearance by GBPs recruited to the PVM. iNOS activation leads to nitration of the vacuole by reactive nitrogen species, causing the collapse of the inner vacuolar network (IVN) which is necessary to evade antigen presentation and may regulate nutrient import from the host and transport of parasite effectors to the host cytosol3,36,37. The efficiency of IVN collapse and iNOS-mediated killing is dependent on the chromosome 3 GBPs, and parasites can evade GBP-clearance in the absence of iNOS, indicating that these two innate immune effector pathways collaborate to mediate vacuole-autonomous parasite clearance in murine myeloid cells.
Results
GBP2 recruitment to the T. gondii PVM is heterogeneous in mouse myeloid cells
To assess the role of immunological stress on T. gondii clearance, bone marrow derived monocytes and dedritic cells (BM-MoDCs) were incubated with media alone, IFNγ and/or the TLR2 ligand Pam3CSK4 (Fig. 1a). BM-MoDCs were then infected with the type II T. gondii strain Me49 engineered to express GFP and luciferase. BM-MoDCs treated with IFNγ alone or IFNγ and Pam3CSK4 efficiently restricted T. gondii growth by 14 h post-infection (Fig. 1b); however, TLR2 stimulation alone was not sufficient for parasite clearance. The IFNγ-dependent clearance corresponded with decreased number of PV and parasites per vacuole by 14 h post-infection (hpi) (Fig. 1c).
To measure parasite vacuole detection by interferon-inducible GTPases, samples were stained with an antibody raised against mouse GBP2. GBP2 was selected because there is evidence that GBP targeting is downstream of p47 IRG recruitment to the vacuole17, GBP2 is the homolog of human GBP1, and GBP2 has been shown to interact with both the parasite vacuole membrane28 and the parasite following vacuole permeabilization26. GBP2 co-localized with 40% of T. gondii vacuoles by two hours post-infection in BM-MoDCs treated with IFNγ or IFNγ and Pam3CSK4 (Fig. 1d), but not in unstimulated or Pam3CSK4-only stimulated conditions. Cytosolic puncta of GBP2 were also observed, consistent with the presence of a non-targeted, vesicular pool of GBP225,26,38. While the total number of parasites decreased over time (Fig. 1b, c) the proportion of GBP2+ and GBP2- vacuoles was similar at 2- and 14-hpi (Fig. 1e). This heterogeneity in GBP targeting is consistent with previous observations in mouse macrophages27 and embryonic fibroblasts (MEFs)28.
iNOS is enriched near parasite vacuoles in IFNγ-treated BM-MoDCs by autoSTOMP
IIG biology is regulated transcriptionally and post-translationally via localization, phosphorylation and prenylation13,14,39,40,41,42. We expected host effectors regulating parasite clearance to be differentially enriched on PV under IFNγ-treated conditions compared to non-restrictive conditions. To identify regulators of IIG-mediated parasite clearance we used automated spatially targeted optical micro proteomics (autoSTOMP)33,34,35 to image and selectively photo-biotinylate proteins in the region surrounding the T. gondii signal in unstimulated, Pam3CSK4, IFNγ or IFNγ and Pam3CSK4 stimulated BM-MoDCs (Fig. 2a, b, PVM). On replicate coverslips, autoSTOMP was used to selectively biotinylate regions where GBP2 colocalized with the T. gondii signal in the IFNγ or IFNγ and Pam3CSK4 stimulated conditions (Fig. 2a, GBP2+). Biotinylated proteins were streptavidin precipitated and identified by liquid chromatography-mass spectrometry (LC-MS) with label-free quantification.
2,070 host proteins were identified across the six PVM and GBP2+ samples (Fig. 2b, Supplementary Data 1). Of these, only 52 proteins were similarly enriched in negative controls where photo-crosslinking did not occur (Supplementary Data 1, Dark controls). Principal component analysis confirmed biological replicates were more similar to each other than differentially stimulated conditions collected and analyzed on the same days (Fig. 2c). Of note, the GBP2+ ‘IFNγ’ and ‘IFNγ and Pam3CSK4’ stimulated conditions clustered tightly (Fig. 2d pink, blue). This indicates that IIG positive vacuole region has a conserved protein signature, independent of TLR2 stimulation. Peptides that did not align to the murine protein library were searched against a T. gondii protein library33, which identified 86 parasite proteins enriched across the six samples (Supplementary Fig. 1). These included rhoptry protein (ROP)7 and ROP5, which localize to the cytoplasmic face of the vacuole after being secreted into the host cytosol43.
As anticipated, several IIGs were highly enriched in PVM and GBP2+ samples under ‘IFNγ’ and ‘IFNγ and Pam3CSK4’ stimulation (Fig. 2d, e). These included IIGP1 (IRGa6)20, TGTP2 (IRGb6)17, IRGM221, GBP1, GBP2, GBP5, and GBP7 which have been shown to localize to the PVM19,20,25,26. In addition, GM4951, a predicted IFN-inducible GTPase, and GVIN1, a very large IFN-inducible GTPase, whose function in T. gondii infection has not been explored, were also identified in proximity to the vacuole. Few proteins were significantly differentially enriched when PVM and GBP2+ samples were compared within the ‘IFNγ’ or the ‘IFNγ and Pam3CSK4’ stimulated conditions (Fig. 2e). Since the resolution of autoSTOMP (~1μm) is wider than the parasite vacuole membrane structure, we sought to determine if sampling of near neighbor regions of the cell could be contributing to this signature by dilating the PVM Map by an additional pixel (~1μm) and identifying proteins in this region (Supplementary Data 1, Supplementary Fig. 2). Although there was a shift towards greater enrichment of GBPs and IRGs in the IFNγ-GBP2 + PVM vs. dilate sample compared to IFNγ-PVM, they were not significantly differentially enriched. Notably, both samples contained some significantly differentially enriched proteins. Thus, we interpret these data to mean that the resolution of autoSTOMP in these assays is ~2 µm and that the technique is identifying a mixture of vacuole-associated proteins and high abundance, near neighbor proteins in the infected cell.
Inducible nitric oxide synthase (iNOS, encoded by the gene Nos2) was among the most enriched proteins in the PVM and GBP2+ regions of IFNγ and Pam3CSK4 stimulated condition (Fig. 2d, e, purple). iNOS was also enriched in the IFNγ-stimulated GBP2+ region relative to the unprimed condition and the IFNγ PVM condition, although this was not statistically significant due to variation in the replicates, and potentially, abundant expression in the cytosol (Fig. 2d, e). Nitric oxide synthetases (endothelial eNOS, neuronal nNOS, and iNOS) produce nitric oxide (·NO) a membrane-diffusible, radical gas that regulates cell signaling44. iNOS is unique in its capacity for transcriptional upregulation in myeloid cells leading to millimolar concentrations of ·NO and conversion to microbicidal reactive species45.
iNOS in myeloid cells is necessary to survive T. gondii infection
An essential role for iNOS in host resistance to T. gondii was first determined in 1997 using whole-body knockout mice46,47. To determine if iNOS expression in myeloid cells was necessary to protect the host from T. gondii in vivo we generated myeloid specific Nos2 knockouts (LysMCre/wtNos2fl/fl). Infected LysMCreNos2fl/fl mice met euthanasia requirements (Fig. 3a, pink), with delayed kinetics compared to whole body knockouts (Fig. 3a, violet), exhibiting more extreme weight loss during acute infection than LysMwtNos2fl/fl controls (Fig. 3b, gray).
To evaluate iNOS-dependent changes in immune infiltrate, peritoneal exudate cells (PECs) were isolated for flow cytometry 9 days post-infection (dpi), before Nos2−/− mice became moribund. Compared to LysMwtNos2fl/fl mice, Nos2−/− and LysMCreNos2fl/fl mice had a significant reduction in Ly6C+ macrophages as well as a compensatory increase in small, panel-negative cells, which were likely lymphocytes (Fig. 3c, Supplementary Fig. 3). Approximately 30% of CD45+ PECs were iNOS-positive in LysMwtNos2fl/fl mice the majority of which were Ly6C+ macrophages (Fig. 3d). In LysMCreNos2fl/fl PECs there was a significant reduction in iNOS+Ly6C+ macrophages. Although the number of iNOS-positive cells varied from mouse to mouse, the mean fluorescence intensity (MFI) of iNOS was significantly lower in the iNOS+LysMCreNos2fl/fl Ly6C+macrophages, Ly6C− macrophages and dendritic cell populations than LysMwtNos2fl/f mice (Fig. 3e), suggesting that iNOS may be upregulated in the myeloid progenitors before the LysM promoter is activated, resulting in residual levels of iNOS proteins in the differentiated cells48. LysM-cre has been reported to drive gene deletion in neutrophils, however, iNOS expression was not observed in neutrophils, Ly6Chi inflammatory monocytes, or the panel negative cells relative to Nos2−/− controls (Fig. 3d, e).
Parasite levels are low in the peritoneal cavity by 9 dpi, nevertheless, there was a significant increase in GFP+ (T. gondii) CD45+ cells in the Nos2−/− compared to the LysMwtNos2fl/f (Fig. 3f). T. gondii load was significantly higher in the spleen, liver, and lung of LysMCreNos2fl/fl compared to LysMwtNos2fl/lf littermates (Fig. 3g), sites of dissemination from the peritoneal cavity. There was a trend toward higher parasite levels in the skeletal muscle, heart, and brain, however, this was not significant, which may reflect the early stage of parasite colonization of these tissues. Based on these data we conclude that optimal iNOS expression in the macrophage and monocyte lineages is necessary to control T. gondii burden and host survival following intra-peritoneal infection.
iNOS activity is necessary for chromosome 3 GBP-mediated T. gondii clearance
The in vivo requirement for iNOS in the myeloid cells and the proximity of iNOS to GBP2+ PVs led us to hypothesize that iNOS is necessary for cell-autonomous clearance of T. gondii in GBP-targeted vacuoles. Consistent with the literature, IFNγ stimulation upregulated Nos2 transcript (Fig. 4a) and protein levels (Fig. 4b) in a way that was significantly enhanced by TLR stimulation49. Notably, T. gondii infection was sufficient to synergize with IFNγ to upregulate iNOS, which is likely due to NF-κB phosphorylation by the parasite effectors GRA1550, GRA2451,52 and/or parasite ligation of TLRs7. By comparison, Nos1 and Nos3 transcripts were not detected in BM-MoDCs (Supplementary Fig. 4a).
To determine if iNOS was necessary for IFNγ-mediated T. gondii clearance, we infected BM-MoDCs from B6 or Nos2−/− animals. INOS deficiency rescued T. gondii growth in BM-MoDCs treated with IFNγ or IFNγ and Pam3CSK4 to levels that were statistically similar to unstimulated BM-MoDCs (Fig. 4c). Blocking iNOS activity with the selective iNOS inhibitor 1400W (Fig. 4d) rescued parasite growth as efficiently as deleting Nos2 (Fig. 4c). In addition, we confirmed that Nos2-deletion did not rescue parasite growth by negatively impacting the transcript expression of chromosome 3 GBPs, effector IRGb6 and IRGb10, or GBP2 protein levels in response to IFNγ (Supplementary Fig. 4b, c).
To determine if IIGs were necessary for iNOS-mediated parasite clearance we interrupted Nos2 (RAWΔNos2) or deleted the chromosome 3 GBPs (RAWΔGbp-chr3) in RAW 264.7 macrophages using CRISPR/Cas9 (Supplementary Fig. 5a–c). iNOS was necessary for IFNγ-mediated parasite clearance in RAW 264.7 macrophages (Fig. 4e, violet). Deleting chromosome 3 GBPs rescued parasite growth in IFNγ-treated RAWs to ~30% of unstimulated levels (Fig. 4e, red vs. black). This degree of rescue was consistent with previous studies in macrophages, but less efficient than iNOS deletion, most likely due to the functional redundancy of chromosome 5 GBPs and/or IRGs24. Importantly, treating IFNγ-stimulated RAWΔGbp-chr3 cells with 1400W did not enhance parasite growth beyond 1400W treatment alone, consistent with the interpretation that iNOS and the chromosome 3 GBPs function in the same pathway rather than additively to promote parasite clearance. IFNγ and TLR stimulation induces endosome maturation which could promote parasite clearance independent of IIGs53. However, chloroquine, which buffers lysosome acidification, did not rescue parasite growth in IFNγ-treated conditions (Supplementary Fig. 5d). Together these data support a model where chromosome 3 GBPs are necessary for optimal iNOS-mediated parasite clearance.
iNOS restricts T. gondii via production of nitric oxide and RNS
We next asked which effector functions of iNOS were responsible for T. gondii clearance. iNOS converts the substrate l-arginine into nitric oxide (•NO) and L-citrulline (Fig. 5a)45. T. gondii is an arginine auxotroph and iNOS activation in macrophages has been proposed to limit T. gondii growth by depleting free arginine54,55. Supplementing l-arginine did not rescue parasite growth in wildtype BM-MoDCs stimulated with IFNγ+Pam3CSK4 compared to Nos2−/− (Fig. 5b). While this experiment does not definitively exclude arginine depletion as a means of limiting T. gondii viability, it prompted us to explore alternative mechanisms of iNOS function.
•NO is a membrane-permeable gas that does not react with most biological molecules until converted to reactive nitrogen species (RNS) via reaction with strong radicals56 (Fig. 5a). RNS, including nitrogen dioxide (•NO2) and peroxynitrite (ONOO-), regulate a range of biological processes by modifying proteins, unsaturated lipids, and nucleic acids57,58. NO was significantly induced by T. gondii infection in IFNγ-stimulated BM-MoDCs or by Pam3CSK4 and IFNγ priming (Fig. 5c, gray bars), mirroring the pattern of iNOS protein expression (Fig. 4b). We next treated BM-MoDCs with the •NO donor DETA NONOate (Fig. 5d) and found that supplementing exogenous •NO sufficient to restore IFNγ-mediated T. gondii clearance in Nos2−/− BM-MoDCs. Notably, NONOate did not restrict T. gondii in unstimulated cells (Fig. 5d) consistent with a model where chromosome 3 GBPs and iNOS cooperate to restrict parasite infection (Fig. 4e). Similarly, expressing human iNOS in RAW cells was not sufficient to restrict T. gondii in unstimulated conditions even though 400 ng/mL doxycycline treatment led to nitrite (NO2-) levels equivalent to IFNγ treatment (Supplementary Fig. 6a, b).
We next examined the role of reactive oxygen species (ROS) in T. gondii clearance. The antioxidant N-acetylcysteine (Supplementary Fig. 7a, NAC) or the mitochondrial ROS scavenger mitoTEMPO (Supplementary Fig. 7b) failed to rescue parasite growth in B6 BM-MoDCs. Moreover, NADPH oxidases were not transcriptionally upregulated in infected RAW 264.7 cells (Supplementary Fig. 7c) and phagosome oxidase (PHOX) components were not enriched at the vacuole in any IFNγ-stimulated autoSTOMP conditions (Supplementary Data 1). Together, these data are consistent with a primary role for RNS downstream of iNOS in GBP-mediated parasite clearance.
Amino acid nitrosylation (R-NO) and nitration (R-NO2) are post-translational modifications that regulate protein-protein and protein-membrane interactions, turnover, and signaling transduction, for example, by competing for phosphorylation sites58,59. Cysteine nitrosylation, is extremely labile, whereas tyrosine nitration is less frequently observed but stable (Fig. 5a)57,60. To determine if the PV is a direct target of RNS, we stained infected macrophages with a nitro-tyrosine (NO2Y)-specific antibody (Fig. 5e–g). Following IFNγ or IFNγ and Pam3CSK4 stimulation robust NO2Y staining co-localized with T. gondii GFP signal (Fig. 5e, f top panel) and, often, the region surrounding the parasite signal (Fig. 5f bottom panel). Tyrosine nitration was remarkably selective for the parasite vacuole, as little NO2Y staining of the host cell was detected. In addition, tyrosine nitration was vacuole selective as macrophages that had been infected multiple times were observed with NO2Y-positive and NO2Y-negative vacuoles (Fig. 5f bottom panel). Tyrosine nitration was reversed by iNOS inhibitor treatment (Fig. 5g). Like our parasite clearance result (Fig. 5d), supplementing •NO in unstimulated conditions was not sufficient to induce appreciable vacuole nitration (Supplementary Fig. 7d). This result suggested that IIGs downstream of IFNγ were necessary for vacuole nitration. To test this directly, we evaluated tyrosine nitration in RAWΔGbp-chr3 (Fig. 5h) and found that there was a significant reduction in NO2Y-positive vacuoles compared to RAW-Cas9 cells. Although it is formally possible that chromosome 3 GBPs play a signaling role distal to the vacuole, these data are consistent with the model that GBP recruitment to the vacuole is necessary for optimal RNS-mediated clearance of parasites downstream of iNOS activation and synthesis of •NO.
iNOS collapses the IVN, limiting parasite escape from GBP clearance
IIG localization to the PVM has been associated with membrane ruffling, permeabilization to cytosolic fluorescent molecules, and T. gondii death19,20,26,27,30. To understand how iNOS cooperates with GBPs to mediate parasite clearance, we asked if iNOS functions upstream or downstream of GBP recruitment to the vacuole. RAW-Cas9 cells and RAWΔNos2 cells had a similar frequency of GBP2+ vacuoles (Fig. 6a–bi), indicating that iNOS was not necessary for GBP2 recruitment. It was immediately apparent that many of the GBP2-positive vacuoles in RAWΔNos2 cells contained morphologically normal, dividing parasites (Fig. 6a, arrowhead). The number of parasites per GBP2-positive vacuole was significantly increased in RAWΔNos2 compared to RAW-Cas9 cells (Fig. 6b-ii). However, the number of parasites per GBP2-negative vacuole was similar, indicating that parasites were not simply growing more efficiently in RAWΔNos2 than RAW-Cas9 cells (Fig. 6b-ii). These data indicate that IIG recruitment is not sufficient to optimally restrict parasite growth in the absence of iNOS, supporting a model of cooperative clearance downstream of IIG recruitment.
To evaluate the vacuole-autonomous cooperation between these pathways we generated RAW-Cas9 cells expressing tetracycline-inducible GBP2 tagged with blue fluorescent protein on the N terminal (mBFP2-GBP2). These cells were stimulated with IFNγ and Pam3CSK4 with or without iNOS inhibitor, then infected with GFP-expressing T. gondii (Fig. 6c, Supplementary Fig. 8). The localization of mBFP2-GBP2 to the vacuole was initiated as early as the first frame (before 1 h) and as late as 16.8 h post-infection (Fig. 6c, left). Loss of parasite-GFP was associated with morphological changes indicative of viability loss (Supplementary Fig. 8a, Supplementary Movie 1). GFP loss on GBP2+ vacuoles were observed from 1 h 20 min to 19 h post-infection (Fig. 6c, Supplementary Fig 8b, c). The iNOS inhibitor 1400W did not change the rate of mBFP2-GBP2 targeting, however, it did delay the median time to loss of GFP signal by 10-h (Fig. 6c, left). Although some parasites were killed when iNOS was inhibited this was significantly reduced compared with IFNγ and Pam3CSK4 treatment (Fig. 6c, right). Confirming static image analysis (Fig. 6a, b) dividing parasites were observed in mBFP2-GBP2+ vacuoles. Two new phenotypes were observed exclusively when iNOS was inhibited. There was a significant increase in GBP-targeted parasite egress from host cells. Moreover, parasites were observed shedding GBP from the vacuole (Fig. 6c, Supplementary Fig. 8, Supplementary Movie 2–4). Cumulatively, these data indicate that iNOS is necessary for the efficient clearance of parasites targeted by GBP2.
To understand how iNOS impacts parasite vacuole structure we evaluated the PV ultrastructure in infected RAW-Cas9 cells using transmission electron microscopy (TEM) (Fig. 6d). Consistent with previous reports17,20,27,30, IFNγ and Pam3CSK4 treatment led to PVM ruffling, discontinuity, and a significant reduction in the IVN area (Fig. 6d, e). Unexpectedly, blocking iNOS activity rescued the IVN volume (Fig. 6d, e, double arrow, and inset) although morphological changes to the PVM were still observed in vacuoles containing one (Fig. 6d, asterisk) or two parasites (Supplementary Fig. 9a). We next sought to distinguish between the possibilities that RNS was required at the onset of infection, to limit IVN biogenesis or RNS could disrupt the IVN once the infection had been established. RAWΔNos2 cells were treated with IFNγ and Pam3CSK4 for 6 h, then pulsed with vehicle or the nitrogen donor NONOate for another 4 h before harvesting for TEM (Supplementary Fig. 9b, c). NONOate treatment led to a significant decrease in the IVN area compared to vehicle, indicating that RNS can collapse the established IVN. In addition, we confirmed that pulsing NONOate into RAWΔNos2 cultures after infection was sufficient to induce parasite clearance by luciferase assay (Supplementary Fig. 9d). Together, these data are consistent with a model where IIGs and RNS target distinct aspects of parasite vacuole biology, moreover, they indicate that PVM disruption by the IIGs alone may not be sufficient for efficient parasite killing.
To understand the requirement of iNOS and the chromosome 3 GBPs on vacuole integrity, we labeled the host cell cytosol with CellMask, blinded the samples, then evaluated the area of the CellMask-negative IVN ‘void’ surrounding each parasite (Fig. 6f). In RAW-Cas9 cells, IFNγ treatment led to a significant reduction in the void area between the T. gondii and host cytosol (Fig. 6g, black). Similar to the TEM results (Fig. 6e), the CellMask-negative void was rescued in RAWΔNos2 cells treated with IFNγ or IFNγ and Pam3CSK4 (Fig. 6g, violet). RAWΔGbp-chr3 cells also had a significant rescue of the void area (Fig. 6g, red). Together these data are consistent with the conclusion that GBP localization to the vacuole and ruffling of the PVM is necessary but not sufficient for efficient parasite clearance in mouse macrophage. In the absence of iNOS activity, parasites can evade GBP attack via egress, GBP shedding, and replication in GBP-targeted vacuoles. Optimal parasite killing requires transcriptional upregulation of iNOS, synthesis of •NO and RNS which modify the PV and collapse the IVN to facilitate parasite clearance in cooperation with the chromosome 3 GBPs (Fig. 6h).
Discussion
Here we have shown that iNOS expression in murine macrophages is necessary for efficient, vacuole-autonomous parasite clearance by GBPs. Early reports evaluating the role of iNOS in T. gondii infection55 used reversible L-arginine analogs to inhibit iNOS and could not discriminate between l-arginine deprivation and RNS production as the mechanism of parasite control61. Our data exclude l-arginine deprivation and implicate •NO synthesis as the critical pathway for killing in a manner that depends on the chromosome 3 GBPs. Similar to indolamine dioxygenase, iNOS has been hypothesized to promote parasite ‘stasis’ in a manner that complements IRGM3 function, however, T. gondii growth rate was not directly measured in this study62. Our data align with a published result from the Yamamoto lab showing that iNOS inhibitor treatment increased the number of parasites per vacuole in peritoneal macrophages from WT mice relative to chromosome 3 GBP-deficient mice24. However, since iNOS inhibition did not change the infection rate, this relationship was not explored further. In addition, skeletal muscle cells treated with IFNγ and TNF have been shown to recruit IRGb6 to the vacuole and produce nitrite in response to Type I and Type II parasite infection; however, a direct relationship between these effector mechanisms was not tested63. Perhaps the most critical evidence supporting the importance of iNOS in T. gondii clearance is the observation that parasites have evolved strategies to inhibit the •NO production64,65 and promote the proteasomal degradation of iNOS64. The Knoll lab found that T. gondii patatin-like protein (TgPL1) limited nitrite synthesis in LPS and IFNγ-stimulated macrophages and protected parasites from degradation66,67, however, the precise mechanism by which TgPL1 interrupts the iNOS/•NO axis is not clear.
In addition to establishing a requirement for iNOS in IFNγ and GBP-mediated parasite clearance, we have found that the PV is robustly and selectively modified by reactive nitrogen species (Fig. 5e). The high levels of •NO flux observed here are expected to lead to dynamic nitration and nitrosylation of lipid, protein and/or nucleic acid substrates57. Although nitrated parasite nucleic acids were not detected using 8-nitroguanine-specific antibodies (data not shown), it is likely that other targets of RNS, including reactive cysteines and unsaturated lipids57,58, also participate in IVN collapse. Unsaturated phospholipid tails in lipid bilayers can serve as nitrogen sinks that target membrane integral proteins for nitration and nitro-lipidation68. However, reliable identification of nitrated lipid species is challenging and there are no tools to evaluate the sub-cellular location of modified lipids. Until recently, tyrosine nitration was posited to be irreversible57,60, which may be why this modification was readily detected in our study. While it is possible that specific NO2Y-modified substrate(s) regulate IVN collapse and parasite clearance, we favor a model where functional redundancy of nitrated/nitrosylated proteins and or lipid targets mediate this biology on GBP-targeted PV57. Future mass spectrometry experiments will be required to identify protein targets of RNS and test the role of these modifications on a case-by-case basis.
The IVN (also called the membranous nanotubular network or, in Plasmodium the tubovesicular network) is a series of host-derived lipid channels connecting the PVM to the parasites and parasites to each other3,36. Initially, the IVN was thought to mediate nutrient acquisition from the host, however, emerging data suggest that the IVN provides structural support for the parasite and is necessary for synchronous division69,70. Many parasite rhoptry and dense granule proteins traffic to the IVN although their roles in this compartment are not entirely clear. It is possible that RNS-modification of parasite proteins in the IVN is leading to growth arrest. Although a series of rhoptry proteins were identified in our autoSTOMP dataset, we did not identify IVN-associated dense granule proteins (Supplementary Fig. 1). This may be related to the low coverage of this technique (~1.0% of 8,315 T. gondii proteins annotated in UniProt) and/or the low abundance of individual GRA proteins rather than their true absence from the GBP2-targeted region. Future studies using autoSTOMP to target the NO2Y-positive vacuolar regions may identify host and/or parasite proteins targeted by RNS as well as mediators of downstream vacuole clearance.
Discovering this role for iNOS has also revealed that GBP recruitment is necessary but not sufficient for optimal IFNγ-dependent parasite clearance in murine macrophages, as previously thought. Our study is consistent with previous TEM data establishing PVM ‘ruffling’ by the chromosome 3 GBPs24 or GBP127. However, our data indicate that these morphological changes to the PVM may not be sufficient for parasite death as iNOS inhibition leads to the enrichment of GBP2 positive vacuoles containing multiple parasites, despite PVM deformity19,30. The increased rates of egress in conditions when iNOS is inhibited indicate that parasites may be able to sense and respond to changes in PVM integrity engaged by the GBPs. Thus, cells that can upregulate an RNS partner mechanism may be more efficient at limiting parasite spread. On the other hand redox stress is a significant cost to host cell biology. It remains to be determined whether other cell types have evolved to efficiently kill T. gondii with the GBP/IRG system independent of RNS or if eNOS/nNOS, which are expressed at far lower levels than iNOS, can participate in parasite killing. Notably, a ‘2-hit model’ of microbial clearance by the GBPs is conceptually consistent with the mechanism discovered by Gaudet et al. where human GBP1 localization to bacterial membranes must partner with an executioner molecule (apolipoprotein (APO) L3) to mediate Salmonella killing71. The role of APOL3 and iNOS in T. gondii clearance from human macrophages remains to be explored. In comparison to the human system where GBP1 is necessary and sufficient for vacuole disruption30,72, in mice IFNγ upregulates the expression of many, partially redundant of IIGs. IRGa618, IRGb617, IRGd16, GBP127, GBP228, and GBP729 have been shown to be necessary for optimal parasite clearance while others, including GBP3, GBP5, and GBP6, can be recruited to the vacuoles already decorated with GBPs26. The precise function of each IIGs on the PVM is not fully understood, and future studies will be necessary to discern which IIGs are necessary for iNOS-mediated IVN collapse.
Finally, our study is the first to formally demonstrate that iNOS expression in myeloid cells is necessary to control T. gondii infection in vivo. The lysM promoter drives expression on a range of bone marrow-derived myeloid cell lineages48. While iNOS was not robustly detected in peritoneal neutrophils, we cannot exclude the contribution of neutrophils at earlier time points or other tissues. Future studies using more selective cre-drivers (eg. Tie2-cre73, CX3CR1-cre74, CD11C-cre75) may inform the role of iNOS in specific macrophage, dendritic cell, or neutrophil populations in host resistance to T. gondii. Previous studies showed Nos2−/− mice succumb to T. gondii by 4 weeks post-infection following IP and oral infection46,47. Lethality was initially attributed to defective parasite restriction in the brain47; however, subsequent studies demonstrated that iNOS is necessary to control hepatic parasite burden46, and iNOS expression in irradiation-sensitive cells was largely responsible for T. gondii protection76. Interestingly, Nos2−/− animals had fewer necrotic lesions in the liver and intestine than wild-type animals, indicating iNOS-mediated parasite clearance comes at the cost of inflammatory damage-to-self46. In our studies, not only did Nos2−/− mice fail to control parasite burden in the peritoneum, liver, spleen, and lung, they met euthanasia requirements by 10 days post-infection (Fig. 3), which was more rapid than previous reports. While it is possible that this discrepancy is due to differences in the gene interruption (our study used deletion of Nos2 exons 12 and 1377 previous studies used deletion of Nos2 exons 1–446,47), the 129Sv mice used to generate the knockout alleles are notably more resistant to acute infection than C57BL/6 mice78. Thus, the limited number of backcrosses used in previous studies (F2 crosses47 or 5 backcrosses46 versus 11 backcrosses77 to C57BL/6 mice used) likely accounts for the delayed lethality. Taken together, this study establishes a new role for iNOS in vacuole autonomous clearance of T. gondii by the chromosome 3 GBPs in murine myeloid cells.
Methods
Inclusion and diversity
We support inclusive, diverse, and equitable conduct of research. Citations in this manuscript were selected to reflect scientific contribution as well as inclusive gender and geographical diversity, whenever possible.
Animals and husbandry
C57BL/6 (Jax #:000664), Nos2−/− (B6.129P2-Nos2tm1Lau/J, Jax #:002609), and CBA/J (Jax #:000656) mice were purchased from the Jackson Laboratory. LysMcreNos2fl/fl mice79 were a gift from Drs. André Marette from Laval University and Dr. Frederick H. Epstein from University of Virginia. Animals were housed in a facility with a 12hr dark/12hr light cycle with temperature of 18–23 °C and 40–60% humidity. Mice were bred and housed in accordance with the University of Virginia Institutional Animal Care and Use Committee, Association for Assessment and Accreditation of Laboratory Animal Care, and Institutional Animal Care and Use Committee Protocol 4107-12-21.
Cell culture
Bone marrow was isolated according to previous publications80,81. Bone marrow was seeded at 1 × 106 in RPMI (Gibco,11875119) + 10%FBS containing 20ng/mL of recombinant GM-CSF (PreproTech, 315-03), fresh differentiation media was added on day 3 and BM-MoDCs were plated for infection on day 7. Loosely attached and adherent cells were collected, counted using trypan blue on the Countess cell counter (Thermo Fisher Scientific), and seeded on tissue culture treated 96-well (Corning 3596) or 24-well plates (Fablab, FL7123). RAW264.7 cells were purchased from ATCC (cat. # TIB71) and maintained according to the ATCC protocol. Plated cells were rested at least 12 h before stimulation.
Parasite infection in vitro
Type II Me49 parasites expressing GFP and luciferase (Me49GLuc) were maintained for up to 10 serial passages on confluent, primary human foreskin fibroblasts (HFFs) in 3 mL of DMEM (Thermo Fisher Scientific, 11965118) + 10% FBS. Intracellular parasites were released by scraping and passage through 22g blunt end needles (Instech Laboratories, LS22/6S). The parasite suspension was centrifuged at 40 × g for 3 min to remove large debris and then washed twice by centrifuging at 300 × g for 6 min each. The pellet was resuspended in DMEM + 10%FBS and counted on the hemocytometer. Parasites were then diluted to the indicated multiplicity of infection (MOI) so that 5 µL of suspension was spiked in every well for infection.
For BM-MoDC infections, cells were seeded at 1 × 106 cell/mL, and media was changed to OptiMEM (Gibco, 31985070) + 1% FBS containing 70 ng/mL of mIFNγ (R&D, 485MI100CF) 20 h before infection. Three hours before infection, Pam3CSK4 (Invivogen, tlrl-pms) was added to the wells at a final concentration of 100 ng/mL. Cells were then infected with Me49GLuc at MOI 1.5.
For infection with RAW 264.7 cells, cells were seeded at 1.5 × 105 cell/mL in DMEM + 10%FBS and media was changed to DMEM + 10%FBS containing 10 ng/mL of mIFNγ 24 h before infection and at the last 3 h, Pam3CSK4 was spiked in to a final of 100 ng/mL. Cells were then infected with Me49GLuc at MOI 5.
At 14 h post-infection, parasite burden was measured using Steady-Luc Firefly HTS Assay Kit (Biotium, 30028-L2) according to the manufacturer’s instructions. The parasite burden was calculated using relative light units (RLU) read from Cytation 5 plate reader (BioTek).
The following inhibitors were added 1 h before infection, unless otherwise noted in the figure legends: 1400W-HCl (100μM, Selleck Chemicals, S8337), L-Arginine (0.5 or 2mM, MP Biomedicals, 0219462625), DETA NONOate (300μM, Cayman Chemical Company, 82120), N-aceyl-l-Cysteine amide (1mM, Cayman Chemical Company, 25866), mitoTEMPO (200 or 500μM, Sigma, SML0737-5MG). Chloroquine (100μM, Thermo Fisher Scientific, 455240250) was added 1 h after infection to avoid impacting parasite invasion.
Immunofluorescence staining and imaging
BM-MoDCs or RAW 264.7 cells were seeded on poly-d-lysine (MP Biomedicals, 0215017550) coated coverslips (Harvard Apparatus, 64-0712) in 24-well plates stimulated and infected as described above. At the time of collection, media was aspirated and cells were fixed by 4% PFA (Electron Microscopy Sciences, 15710) for 15 min at room temperature. Samples were washed twice with PBS, permeabilized with PBS + 1% Triton X-100 (Fisher) for 30 min, and blocked with PBS + 5% BSA (Fisher) or serum of the host of secondary antibodies (Jackson ImmunoResearch). Coverslips were incubated with primary antibodies overnight at 4 °C, followed by 3 washes with PBS, and incubation with fluorescent secondary antibodies. After 3 washes and DAPI staining (Thermo Fisher Scientific, D1306), coverslips were mounted in the ProLong Gold Antifade Mountant (Thermo Fisher Scientific, P36930) or Vectashield Mounting Medium (Vector Laboratories, H-1000-10). Coverslips were imaged on Zeiss LSM 880 (Carl Zeiss) using 40x (Plan-Apochromat NA1.3, Oil DIC M27) or 63x (Plan-Apochromat NA1.4, Oil DIC M27) lenses.
Primary antibodies used: α-GBP2 (Proteintech, 11854-1-AP, 1:500 dilution), α-Toxoplasma polyclonal (Thermo Fisher Scientific, PA1-7253, 1:500 dilution), α-TgSAG1 (Thermo Fisher Scientific, MA518268, 1:100 dilution), α-iNOS (BD Biosciences, 610328, 1:500 dilution),, α-nitrotyrosine (EMD Millipore, 06–284, 1:200 dilution). Following secondary antibodies were used at 1:500 dilution: Goat anti-Rabbit IgG (H + L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 594 (Thermo Fisher Scientific, A11037); AffiniPure Donkey Anti Mouse IgG (H + L), Alexa Fluor 594 (Jackson ImmunoResearch, 715-585-150); Donkey anti-Rabbit IgG (H + L) Highly Cross Adsorbed Secondary Antibody, Alexa Fluor 647 (Thermo Fisher Scientific, A31573).
autoSTOMP procedure and LC-MS
AutoSTOMP was performed as published previously33,34. Briefly, B6 BM-MoDCs were seeded on 18 mm coverslips (Thomas Scientific, 1217N81) at 1.35 x 106 cells per coverslip in 12 well plates. Cells were treated with RPMI + 10%FBS containing 70 ng/mL of mIFNγ 16 h before the infection and at the last 3 h, Pam3CSK4 was added to a final concentration of 100 ng/mL. Cells were then infected with Me49GLuc at MOI 1.5. Samples were harvested at 2 h.p.i by fixing in cold absolute methanol (Fisher) for 20 min on ice and stained following the IF staining protocol including avidin/biotin blocking (Vector Laboratories, SP-2001) following the manufacturer’s instructions. Slides were stored at −30 and mounted immediately prior to autoSTOMP imaging in 1 mM biotin-dPEG3-benzophenone (Quanta BioDesign, Biotin-BP) in 50:50 (v/v) dimethyl sulfoxide (DMSO)/water. Slides were subjected to autoSTOMP procedure on Zeiss LSM 880 microscope (Carl Zeiss) with a Chameleon multiphoton light source (Coherent) and a 25x oil immersion lens (LD LCI Plan-Apochromat 25×/0.81 mm Korr DIC M27). Regions of interest were defined as the 1 pixel region surrounding all T. gondii signal was defined as the ‘PVM’ MAP or the region of GBP2+ staining overlapping or immediately adjacent to the T. gondii signal was defined as the ‘GBP2’ MAP. The specificity of photo-biotinylation was confirmed by Streptavidin-594 secondary staining and ‘dark controls,’ where samples were not exposed to 2 photon excitation, were performed on unstimulated (N = 2, labeled ‘Dark 1’ and ‘Dark 2’) and IFNy stimulated (N = 1, ‘Dark 3’) conditions as described in ref. 33. The dilate control (n = 3) was performed on the IFNγ-stimulated conditions where the PV region was dilated by 1 pixel to biotinylated the region surrounding but excluding the region targeted for the ‘PVM’‘ sample. A detailed protocol and source codes are available at [https://github.com/boris2008/Sikulix-automates-a-workflow-performed-in-multiple-software-platforms-in-Windows].
After autoSTOMP crosslinking samples were washed, dissociated from the coverslips in 8 M urea lysis buffer (100 mM NaCl, 25 mM Tris, 2% SDS, 0.1% tween 20, 2 mM EDTA, 0.2 mM PMSF, and 1x Roche cOmpleteProtease inhibitor). Lysates were treated with benzonase (Sigma, E1014-25KU) and RNase (Sigma, 10109142001) to reduce viscosity then subjected to affinity purification using Pierce Streptavidin Magnetic Beads (Thermo, 88817). Enriched proteins were eluted by boiling at 96 °C for 5 min in Laemmli SDS buffer (10µM DTT, 0.0005% Bromophenol blue, 10% Glycerol, 2% SDS, 63 mM Tris-HCl pH 6.8) and ran on a pre-cast Novex Tris-Glycine Mini Protein gel (Thermo Fisher Scientific, XP04125BOX) at 70 V for 12 min. 1 cm gel fragments were cut from each lane and submitted to University of Virginia Biomolecular Analysis Facility for mass spectroscopy analysis. The samples were run on a Thermo Orbitrap Exploris 480 mass spectrometer system with an Easy Spray ion source connected to a Thermo 75 μm × 15 cm C18 Easy Spray column (trap column first). Mass spectra data were analyzed using MaxQuant (versions 1.6.15.0) following the published pipeline and maxLFQ data were analyzed in Perseus (version 2.0.3.1) using Student’s t-test (permutation-based FDR)33,34. Plots were generated using R (version 4.2.0) and GraphPad Prism 9.
Mouse infection
Age and sex-matched animals were infected between 12–18 weeks old. 2 weeks before infection, dirty bedding was mixed to normalize the microbiota. Me49GLuc cysts were passed in vivo ib CBA/J mice to harvest cysts from brain tissue, as previously published82. The brain lysate was 1:10 diluted in the PBS and stained with rhodamine-labeled dolichos biflorus agglutinin (DBA-red, Vector Laboratories, RL-1032-2). GFP and DBA-red double-positive cysts were counted and diluted to 5 cysts per 200 µL of PBS. Mice were injected with 200 µL of cyst solution and were monitored using a humane endpoint scoring system based on weight loss, posture, appearance, and activity. Moribund mice were euthanized according to the ACUC protocol.
Flow cytometry
Cells in the peritoneal cavity were isolated by lavage with 10 mL of cold PBS. Cell number was determined by Countess hemocytometry (Thermo Fisher Scientific). 1.2 × 106 total cells were isolated for FACS staining in a round bottom 96-well plate. Cells were pelleted down at 1,500 x g at 4 °C for 5 min and cell pellets were resuspended in 100 µL FACS buffer (PBS + 4% FBS + 0.5 mM EDTA) containing Fc block (BioLegend, 101302, 1:200). After 15 min incubation at 4 °C, surface markers were stained with following antibodies at 1:200 dilution at 4 °C for 30 min: CD11b-Pacific Blue (BioLegend, 101224), CD45-BV650 (BioLegend, 103151), CD11c-BV711 (BioLegend, 117349), Ly6C-PerCP/Cy5.5 (BioLegend, 128012), F4/80-PE/Cy7 (BioLegend, 123113), I-A/I-E-AF647 (BioLegend, 107618), Ly6G-APC/Cy7 (BioLegend, 127624). Staining was stopped by 2 washes in FACS buffer, fixation, and permeabilized using BD Cytofix/Cytoperm fixation/permeabilization kit (BD Biosciences, 554714). Intracellular iNOS was stained with iNOS-AF594 (BioLegend, 696803, 1:200) in the FACS buffer for 1 h at room temperature in the dark. Cells were then washed twice using BD Perm/Wash buffer and resuspended in 200 µL of FACS buffer. Single stains were prepared using UltraCom eBeads (Thermo Fisher Scientific, 01-2222-42) as well as fluorescence minus one (FMO) controls. Samples were run on an Attune Flow Cytometer (Thermo Fisher Scientific) equipped with 405 nm, 488 nm, 561 nm, 637 nm lasers, and 14 detector channels. Data were analyzed using FlowJo (v10.8) and gated using FMOs.
Genomic DNA preparation from tissue
Tissues were dissected and flash-frozen on liquid nitrogen. 1 µL of UltraPure water (Thermo Fisher Scientific, 10977015) was added per 1 mg of tissue, then bead beaten (Qiagen, 69989) using a Qiagen Tissuelyzer (Qiagen) for 3 min at 25 Hz. 20 µL of tissue lysates were taken for DNA isolation using DNeasy Blood & Tissue Kit (Qiagen, 69506) according to the manufacturer’s instruction. Eluted DNA was quantified on the NanoDrop One (Thermo Fisher Scientific) and diluted to the same concentration. 50 ng of total DNA from each sample was used for quantitative PCR (qPCR).
Quantitative PCR
T. gondii burden in the tissue was measured by qPCR of T. gondii 529-bp repeat element (RE) compared with mouse β-actin as described previously83 using Taqman probes (Thermo Fisher Scientific). Water or uninfected animals were used as a negative control. Data were analyzed using the ΔCt method. The following TaqMan primer/probes were used: 529-bp RE forward, 5′-CACAGAAGGGACAGAAGTCGAA-3′ and reverse, 5′-CAGTCCTGATATCTCTCCTCCAAGA-3′; probe: 5′-CTACAGACGCGATGCC-3 (Integrated DNA Technologies); mouse β-actin: Mm02619580_g (Thermo Fisher Scientific).
For tissue culture experiments, total RNAs were isolated using Quick-RNA Miniprep Kit (Zymo Research, R1055). RNA concentration and quality were assessed by NanoDrop (Thermo Fisher Scientific). 40 ng of total RNA was used for cDNA synthesis using Accuris qMax cDNA Synthesis Kit (Accuris Instruments, PR2100-C-250). Gene expression levels were measured by reverse transcription quantitative PCR (RT-PCR) using PowerUp SYBR Green PCR Master Mix (Thermo Fisher Scientific, A25742). Primers are listed in Supplementary Data 3 and ΔCt was calculated relative to Actb gene while relative gene expression levels were quantified using ΔΔCt method normalizing to unstimulated groups. No RT control was included as a negative control. All of the above procedures were carried out according to the manufacturer’s instructions.
Western blot
At the time of collection, media was removed, and cell lysates were prepared by directly adding Laemmli SDS buffer into the well. Protein lysates were transferred out of the plate, sonicated twice on ice, and denatured at 95 °C for 5 min. Lysates were loaded on 10% home-made SDS-PAGE gel and transferred onto a 0.45 µm PVDF membrane (Millipore, IPFL00010) using TransBlot Turbo System (Bio-Rad). The membranes were blocked in TBST containing 5% skim milk at room temperature for 1 h, followed by primary antibody incubation at 4 °C overnight. After three TBST washes, membranes were incubated in TBST containing HRP-conjugated secondary antibodies at room temperature for 1 h. Luminata Forte Western HRP substrate (Millipore, WBLUF0100) and ChemiDoc Imager (Bio-Rad) were used to develop the membrane and acquire images respectively. Volumetric intensities were quantified using Image Lab software (Bio-Rad, version 6.0.0). Primary antibodies used: α-GBP2 (Proteintech, 11854-1-AP, 1:1000 dilution), α-iNOS (BD Biosciences, 610328, 1:1000 dilution), α-GAPDH (CST, 5174, 1:1000 dilution). Secondary antibodies used: Peroxidase AffiniPure Goat Anti-Mouse IgG (Jackson ImmunoResearch, 115-035-003, 1:10,000 dilution), Peroxidase AffiniPure Donkey Anti-Rabbit IgG (Jackson ImmunoResearch, 711-035-152, 1:10,000 dilution).
NO and nitrite measurement
Intracellular NO levels were measured using OxiSelect Intracellular Nitric Oxide (NO) Assay Kit (Cell Biolabs, STA-800-5). Nitrite levels in the cleared supernatant were measured using Griess Reagent Kit (Thermo Fisher Scientific, G7921) according to the manufacturer’s instructions and detected on a Cytation5 plate reader.
Plasmids
pLIX-hNos2 (Addgene, 110800), psPAX2 (Addgene, 12260), pMD2.G (Addgene, 12259), LentiGude Puro (Addgene, 52963) were purchased from Addgene. CAS9 Blasticidin Lenti plasmid was purchased from Sigma (CAS9BST). Plasmids were expanded in house and isolated using Plasmid Plus Midi Kit (Qiagen, 12945) according to the manufacturer’s instructions.
sgRNA targeting the respective gene was designed on E-CRISP and lentivectors expressing sgRNAs were built according to the published protocol84. Primers used to generate the sgRNA plasmids were listed in Supplementary Data 3.
LentiGuide-Gbp-Chr3-sg3+sg4 carrying both Gbp-Chr3 sgRNA3 and sgRNA4 generated by first building individual LentiGuide plasmids as stated above. Amplicon containing U6 promoter and sgRNA4 was PCR amplified using Phusion High-Fidelity DNA Polymerase (New England Biolabs, M0530) and assembled into SalI linearized LentiGuide-GBP-Chr3 sgRNA3 plasmid using HiFi DNA Assembly Kit (New England Biolabs, E5520). Primers used were listed in Supplementary Data 3.
pLIX-Gbp-Chr3-repair plasmid containing a neomycin resistance cassette (NeoR) targeting chromosome 3 GBP locus was generated from genomic DNA by amplifying 5’ and 3’ homology arms using primers listed in Supplementary Data 3. The protospacer adjacent motif (PAM) loci of sgRNA were mutated in the amplicons of homology arms. The NeoR gene fragment was synthesized by GeneWiz. All fragments were assembled into a pLIX plasmid linearized by NheI and SalI (New England Biolabs) using HiFi DNA Assembly Kit (New England Biolabs, E5520). All plasmids were Sanger sequenced to ensure correct inserts (Eurofins Scientific).
Tetracycline inducible pLV-Hygro-TRE3G-mTagBFP2-GBP2 plasmid was custom made by VectorBuilder and the vector ID is VB230707-1304hwk, which can be used to retrieve detailed information about the vector on vectorbuilder.com. The full plasmid sequence is included in the Supplementary Data 3.
Lentiviral transduction
HEK-293T cells were seeded 1 day before transfection and transfected with psPAX2, pMD2.G packaging plasmid, and lentivectors using Fugene 6 (Promega, E2691). 24 h after transfection, media was changed. After 48 h viral supernatants were collected, cleared of cell debris using 0.45 μm filter (Celltreat, 229766) and added to target cells in the presence of polybrene (EMD Millipore, TR-1003-G). After overnight incubation, fresh media was added. Two days later, cells were selected in 6 μg/mL of puromycin (Sigma, P8833) or 7 μg/mL blasticidin (Research Product International, B122000) for 2 days. Surviving cells were expanded and single-cell cloned.
Generation of RAWΔGbp-chr3
Fourteen micrograms of pLIX-Gbp-Chr3-repair plasmid were linearized using NheI and SalI. Purified templates together with 2 µg of LentiGuide-Gbp-Chr3-sg3+sg4 were electroporated into RAW-Cas9 cells using Lonza SF cell line X kit (Lonza, V4XC-2012) on a Lonza 4D-Nucleofector unit (Lonza). Code DS-136 was used for electroporation. Cells were flushed out using warm complete DMEM + 10%FBS and rested for 4 days. 1 mg/mL of G418 (Thermo Fisher Scientific, BP6735) was added for 4 days. G418 was added every 2 passages to keep the selection pressure. Successful insertion of the repair template was validated by PCR using primers listed in Supplementary Data 3.
CellMask staining
Cells and coverslips were prepared as described above. Fixation is followed by a gentle permeabilization with 0.2% (w/v) BSA and 0.02% (w/v) Saponin in PBS (w/o Mg2+, Ca2+) for 30 min at RT and then blocked in PBS + 5% BSA for 15 min at RT. Primary antibodies were applied for 1h in the permeabilization buffer as described elsewhere. After three 5 min washes, secondary antibodies were prepared in permeabilization buffer containing 2 μg/ml HCS CellMask Blue Stain (Invitrogen Molecular, H32729) and incubated at RT for 30 min protected from light. Following 4 washes, coverslips were mounted with ~25 µl ProLong Glass Antifade Mountant (Thermo, P36980) and left to fully cure overnight in the dark at RT before imaging or longer-term cold storage. The area of the cell mask negative void and the parasite GFP signal was analyzed in Fiji.
Transmission electron microscopy
5.0 × 106 RAW 264.7 cells were plated into three 10cm dishes and incubated overnight at 37 °C with 5% CO2. Subsequently, appropriate dishes were primed with 10ng/ml mIFNγ and Pam3CSK4 for 24 h prior to infection. An hour before infection, one primed dish was treated with 100 μM 1400W. Both dishes were infected for 6 h with Type II Me49-GFP-Luc at MOI 2, following which cells were washed thrice with ice-cold PBS. In a second experiment, RAWΔNos2 cells were seeded, stimulated and infected as described above. 6 h post-infection one dish was treated with DETA NONOate (300 μM, Cayman Chemical Company, 82120) and a second was treated with vehicle control and samples were harvested 4 h later.
Simultaneously, a fixation buffer was freshly prepared with 2.5% glutaraledehyde, 0.1M sodium cacodylate (both Sigma-Aldrich, G5882-50ML, and C4945-10G, respectively), and sterile deionized H2O. The buffer was applied to the cells, which were then allowed to fix at room temperature for 1 h. Cells were scraped gently into ‘sheets’ and collected into 2-ml Eppendorf tubes, centrifuged, and washed thrice with 0.1M sodium cacodylate. They were stored at 4 °C in a 0.1M sodium cacodylate buffer with minimal air exposure.
For ultrastructural analysis, cells were washed with 0.1M sodium cacodylate twice, immersed in 1% osmium tetraoxide (Sigma-Aldrich, 75632) in 0.1M sodium cacodylate at RT for 1 h, then washed again. Dehydration was carried out using an ethanol gradient (50%, 70%, 95%, and 100%), each for 10 min. A series of infiltration steps using an increasing ratio of epoxy resin was executed. Polymerization was performed overnight at 60 °C. Ultrathin sections (80 nm) were cut using a Leica EM UC7 Ultramicrotome, collected on 200 mesh copper grids, counterstained with uranyl acetate and lead citrate, and carbon-coated for TEM stability. Samples were stored at RT until imaging. Samples were imaged on a FEI Tecnai F20 equipped with a 4K camera (TSS microscopy). All images were blinded and the area of the intravacuolar network (IVN) space was analyzed in Fiji.
Live imaging
To visualize RAW-Cas9 cells transduced with tetracyclin-inducible GBP2 tagged with blue fluorescent protein, mTagBFP2, in the N-terminal (mBFP2-GBP2) were plated on poly-D-lysine coated chambered slides (MP Biomedicals, 0215017550) at 2 × 105/well in FluoroBrite DMEM (Thermo Fisher, A1896701) and 10% FBS. Cells were treated with 400ng/ml anhydrotetracycline (400ng/mL, Cayman Chemical Company, cat. 10009542) 44 h before infection. 24 h before infection cells were primed with 10ng/mL mIFNγ, 3 h before infection 10ng/mL Pam3CSK4 was added. Cells were infected with Me49-GFP-luc at MOI = 5. Live imaging was performed at the Keck Molecular Imaging Core Zeiss LSM980 using a 20x objective (Plan-Apochromat, NA 0.8 M27). 3 z-stacks covering 8 microns were acquired at 20-min intervals across a 3x2 tiles scan. Each experiment lasted 20 h. Data are quantified from 1 to 20 h post-infection in Zen Black.
Antibodies
All antibodies used in this study are listed in Supplementary Table 1
Statistical analysis
Data were plotted and analyzed in GraphPad Prism 9 and R (version 4.2.0) unless noted otherwise. A normality test was carried out whenever possible to choose appropriate statistical analysis.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Data availability
The raw mass spectrometry data of autoSTOMP have been deposited in PRIDE database [https://www.ebi.ac.uk/pride/] under accession code PXD027716. Source data are provided with this paper through Figshare and can be accessed through this link [https://doi.org/10.6084/m9.figshare.24907851]. Source data are provided with this paper.
Code availability
Source codes are freely available at [https://github.com/boris2008/Sikulix-automates-a-workflow-performed-in-multiple-software-platforms-in-Windows] The source code is also deposited to Zenodo with [https://doi.org/10.5281/zenodo.10674574].
References
Dubey, J. P., Lindsay, D. S. & Speer, C. A. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin. Microbiol. Rev. 11, 267–299 (1998).
Wong, S. Y. & Remington, J. S. Biology of Toxoplasma gondii. Aids 7, 299–316 (1993).
Caffaro, C. E. & Boothroyd, J. C. Evidence for host cells as the major contributor of lipids in the intravacuolar network of Toxoplasma-infected cells. Eukaryot. Cell 10, 1095–1099 (2011).
Mordue, D. G., Håkansson, S., Niesman, I. & David Sibley, L. Toxoplasma gondii resides in a vacuole that avoids fusion with host cell endocytic and exocytic vesicular trafficking pathways. Exp. Parasitol. 92, 87–99 (1999).
Benson, A., Pifer, R., Behrendt, C. L., Hooper, L. V. & Yarovinsky, F. Gut Commensal Bacteria Direct a Protective Immune Response against Toxoplasma gondii. Cell Host Microbe 6, 187–196 (2009).
Denkers, E. Y. A Gut Feeling for Microbes: Getting It Going between a Parasite and Its Host. Cell Host Microbe 6, 104–106 (2009).
Yarovinsky, F. et al. Immunology: TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308, 1626–1629 (2005).
Heimesaat, M. M. et al. Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following Oral Infection with Toxoplasma gondii. J. Immunol. 177, 8785–8795 (2006).
Molloy, M. J. et al. Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. Cell Host Microbe 14, 318–328 (2013).
Yap, G., Pesin, M. & Sher, A. Cutting edge: IL-12 is required for the maintenance of IFN-γ production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol. 165, 628–631 (2000).
Scanga, C. A. et al. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168, 5997–6001 (2002).
Tsitsiklis, A., Bangs, D. J. & Robey, E. A. CD8+ T cell responses to Toxoplasma gondii: lessons from a successful parasite. Trends Parasitol. 35, 887–898 (2019).
Dockterman, J. & Coers, J. How did we get here? Insights into mechanisms of immunity-related GTPase targeting to intracellular pathogens. Curr. Opin. Microbiol. 69, 102189 (2022).
Saeij, J. P. & Frickel, E. M. Exposing Toxoplasma gondii hiding inside the vacuole: a role for GBPs, autophagy and host cell death. Curr. Opin. Microbiol. 40, 72–80 (2017).
Haldar, A. K. et al. IRG and GBP host resistance factors target aberrant, ‘non-self’ vacuoles characterized by the missing of ‘self’ IRGM proteins. PLoS Pathog. 9, e1003414 (2013).
Collazo, C. M. et al. Inactivation of LRG-47 and IRG-47 reveals a family of interferon γ-inducible genes with essential, pathogen-specific roles in resistance to infection. J. Exp. Med. 194, 181–187 (2001).
Lee, Y. et al. Initial phospholipid-dependent Irgb6 targeting to Toxoplasma gondii vacuoles mediates host defense. Life Sci. Alliance 3, e201900549 (2020).
Liesenfeld, O. et al. The IFN-γ-inducible GTPase, irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens. PLoS ONE 6, e20568 (2011).
Zhao, Y. O., Khaminets, A., Hunn, J. P. & Howard, J. C. Disruption of the Toxoplasma gondii parasitophorous vacuole by IFNγ-inducible immunity-related GTPases (IRG proteins) triggers necrotic cell death. PLoS Pathog. 5, e1000288 (2009).
Martens, S. et al. Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog. 1, 0187–0201 (2005).
Pradipta, A. et al. Cell-Autonomous Toxoplasma killing program requires Irgm2 but not its microbe vacuolar localization. Life Sci. Alliance 4, 1–15 (2021).
Dockterman, J., Fee, B. E., Taylor, G. A. & Coers, J. Murine Irgm paralogs regulate nonredundant functions to execute host defense to Toxoplasma gondii. Infect. Immun. 89, e0020221 (2021).
Taylor, G. A. et al. Pathogen-specific loss of host resistance in mice lacking the IFN-γ-inducible gene IGTP. Proc. Natl Acad. Sci. USA 97, 751–755 (2000).
Yamamoto, M. et al. A cluster of interferon-γ-inducible p65 gtpases plays a critical role in host defense against Toxoplasma gondii. Immunity 37, 302–313 (2012).
Degrandi, D. et al. Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. J. Immunol. 179, 7729–7740 (2007).
Kravets, E. et al. Guanylate binding proteins directly attack Toxoplasma gondii via supramolecular complexes. Elife 5, 1–30 (2016).
Selleck, E. M. et al. Guanylate-binding protein 1 (Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii. PLoS Pathog. 9, e1003320 (2013).
Degrandi, D. et al. Murine Guanylate Binding Protein 2 (mGBP2) controls Toxoplasma gondii replication. Proc. Natl Acad. Sci. USA 110, 294–299 (2013).
Steffens, N. et al. Essential role of mGBP7 for survival of Toxoplasma gondii infection. MBio 11, 1–14 (2020).
Fisch, D. et al. Human GBP1 differentially targets Salmonella and Toxoplasma to license recognition of microbial ligands and caspase-mediated death. Cell Rep. 32, 108008 (2020).
Barylyuk, K. et al. A subcellular atlas of Toxoplasma reveals the functional context of the proteome. Cell Host Microbe 28, 752–766.e9 (2020).
Cygan, A. M. et al. Proximity-labeling reveals novel host and parasite proteins at the Toxoplasma parasitophorous vacuole membrane. MBio 12, 2021.02.02.429490 (2021).
Yin, B. et al. Automated Spatially Targeted Optical Microproteomics (autoSTOMP) to determine protein complexity of subcellular structures. Anal. Chem. 92, 2005–2010 (2020).
Yin, B. et al. Automated spatially targeted optical microproteomics investigates inflammatory lesions in situ. J. Proteome Res. 20, 4543–4552 (2021).
Hadley, K. C. et al. Determining composition of micron-scale protein deposits in neurodegenerative disease by spatially targeted optical microproteomics. Elife 4, 1–21 (2015).
Cesbron-D.delauw, M. F., Gendrin, C., Travier, L., Ruffiot, P. & Mercier, C. Apicomplexa in mammalian cells: trafficking to the parasitophorous vacuole. Traffic 9, 657–664 (2008).
Lopez, J. et al. Intravacuolar membranes regulate CD8 T cell recognition of membrane-bound Toxoplasma gondii protective antigen. Cell Rep. 13, 2273–2286 (2015).
Vestal, D. J., Gorbacheva, V. Y. & Sen, G. C. Different subcellular localizations for the related interferon-induced GTPases, MuGBP-1 and MuGBP-2: Implications for different functions? J. Interf. Cytokine Res. 20, 991–1000 (2000).
Modiano, N., Lu, Y. E. & Cresswell, P. Golgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-γ-inducible cofactor. Proc. Natl Acad. Sci. USA 102, 8680–8685 (2005).
Behnke, M. S. et al. The polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18. PLoS Pathog. 8, e1002992 (2012).
Fentress, S. J. et al. Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence. Cell Host Microbe 8, 484–495 (2010).
Steinfeldt, T. et al. Phosphorylation of mouse immunity-related gtpase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii. PLoS Biol. 8, e1000576 (2010).
Ihara, F. & Nishikawa, Y. Toxoplasma gondii manipulates host cell signaling pathways via its secreted effector molecules. Parasitol. Int. 83, 102368 (2021).
Cooke, J. P. & Dzau, V. J. Nitric oxide synthase: role in the genesis of vascular disease. Annu. Rev. Med. 48, 489–509 (1997).
Cinelli, M. A., Do, H. T., Miley, G. P. & Silverman, R. B. Inducible nitric oxide synthase: regulation, structure, and inhibition. Med. Res. Rev. 40, 158–189 (2020).
Khan, I. A., Schwartzman, J. D., Matsuura, T. & Kasper, L. H. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc. Natl Acad. Sci. USA 94, 13955–13960 (1997).
Scharton-Kersten, T. M., Yap, G., Magram, J. & Sher, A. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185, 1261–1273 (1997).
Abram, C. L., Roberge, G. L., Hu, Y. & Lowell, C. A. Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice. J. Immunol. Methods 408, 89–100 (2014).
Kleinert, H., Schwarz, P. M. & Förstermann, U. Regulation of the expression of inducible nitric oxide synthase. Biol. Chem. 384, 1343–1364 (2003).
Rosowski, E. E. et al. Strain-specific activation of the NF-κB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J. Exp. Med. 208, 195–212 (2011).
Braun, L. et al. A Toxoplasma dense granule protein, GRA24, modulates the early immune response to infection by promoting a direct and sustained host p38 MAPK activation. J. Exp. Med. 210, 2071–2086 (2013).
Mercer, H. L. et al. Toxoplasma gondii dense granule protein GRA24 drives MyD88-independent p38 MAPK activation, IL-12 production and induction of protective immunity. PLoS Pathog. 16, e1008572 (2020).
Sanjuan, M. A., Milasta, S. & Green, D. R. Toll-like receptor signaling in the lysosomal pathways. Immunol. Rev. 227, 203–220 (2009).
Fox, B. A., Gigley, J. P. & Bzik, D. J. Toxoplasma gondii lacks the enzymes required for de novo arginine biosynthesis and arginine starvation triggers cyst formation. Int. J. Parasitol. 34, 323–331 (2004).
Langermans, J. A. et al. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. J. Immunol. 148, 568–574 (1992).
Radi, R. Oxygen radicals, nitric oxide, and peroxynitrite: redox pathways in molecular medicine. Proc. Natl Acad. Sci. USA 115, 5839–5848 (2018).
Pérez de la Lastra, J. M., Juan, C. A., Plou, F. J. & Pérez-Lebeña, E. The nitration of proteins, lipids and DNA by peroxynitrite derivatives-chemistry involved and biological relevance. Stresses 2, 53–64 (2022).
Bartesaghi, S. & Radi, R. Fundamentals on the biochemistry of peroxynitrite and protein tyrosine nitration. Redox Biol. 14, 618–625 (2018).
Thomas, D. D. et al. The chemical biology of nitric oxide: Implications in cellular signaling. Free Radic. Biol. Med. 45, 18–31 (2008).
Balabanli, B., Kamisaki, Y., Martin, E. & Murad, F. Requirements for heme and thiols for the nonenzymatic modification of nitrotyrosine. Proc. Natl Acad. Sci. USA 96, 13136–13141 (1999).
Adams, L. B., Hibbs, J. B., Taintor, R. R. & Krahenbuhl, J. L. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J. Immunol. 144, 2725–2729 (1990).
Zhao, Y. et al. Virulent Toxoplasma gondii evade immunity-related GTPase-mediated parasite vacuole disruption within primed macrophages. J. Immunol. 182, 3775–3781 (2009).
Takács, A. C., Swierzy, I. J. & Lüder, C. G. K. Interferon-γ restricts Toxoplasma gondii development in murine skeletal muscle cells via nitric oxide production and immunity-related GTPases. PLoS ONE 7, e45440 (2012).
Padrão, J. et al. Toxoplasma gondii infection of activated J774-A1 macrophages causes inducible nitric oxide synthase degradation by the proteasome pathway. Parasitol. Int. 63, 659–663 (2014).
de Abreu Cabral, G. R., Wang, Z. T., Sibley, L. D. & DaMatta, R. A. Inhibition of nitric oxide production in activated macrophages caused by Toxoplasma gondii infection occurs by distinct mechanisms in different mouse macrophage cell lines. Front. Microbiol. 9, 1–11 (2018).
Mordue, D. G., Scott-Weathers, C. F., Tobin, C. M. & Knoll, L. J. A patatin-like protein protects Toxoplasma gondii from degradation in activated macrophages. Mol. Microbiol. 63, 482–496 (2007).
Tobin, C. M. & Knoll, L. J. A patatin-like protein protects Toxoplasma gondii from degradation in a nitric oxide-dependent manner. Infect. Immun. 80, 55–61 (2012).
Batthyany, C. et al. Reversible post-translational modification of proteins by nitrated fatty acids in vivo. J. Biol. Chem. 281, 20450–20463 (2006).
Travier, L. et al. Functional domains of the Toxoplasma GRA2 protein in the formation of the membranous nanotubular network of the parasitophorous vacuole. Int. J. Parasitol. 38, 757–773 (2008).
Magno, R. C., Lemgruber, L., Vommaro, R. C., De Souza, W. & Attias, M. Intravacuolar network may act as a mechanical support for Toxoplasma gondii inside the parasitophorous vacuole. Microsc. Res. Tech. 67, 45–52 (2005).
Gaudet, R. G. et al. A human apolipoprotein L with detergent-like activity kills intracellular pathogens. Science 373, eabf8113 (2021).
Fisch, D., Clough, B., Khan, R., Healy, L. & Frickel, E. M. Toxoplasma-proximal and distal control by GBPs in human macrophages. Pathog. Dis. 79, ftab058 (2021).
Kisanuki, Y. Y. et al. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 230, 230–242 (2001).
Yona, S. et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 79–91 (2013).
Caton, M. L., Smith-Raska, M. R. & Reizis, B. Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J. Exp. Med. 204, 1653–1664 (2007).
Yap, G. S. & Sher, A. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-γ- and tumor necrosis factor (TNF)-α- dependent host resistance to the intracellular pathogen, Toxoplasma gondii. J. Exp. Med. 189, 1083–1091 (1999).
Laubach, V. E., Shesely, E. G., Smithies, O. & Sherman, P. A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl Acad. Sci. USA 92, 10688–10692 (1995).
Clough, B. et al. C57BL/6 and 129 inbred mouse strains differ in Gbp2 and Gbp2b expression in response to inflammatory stimuli in vivo. Wellcome Open Res. 4, 124 (2019).
Vilela, V. R. et al. Adipocyte-specific Nos2 deletion improves insulin resistance and dyslipidemia through brown fat activation in diet-induced obese mice. Mol. Metab. 57, 101437 (2022).
Lutz, M. B. et al. Guidelines for mouse and human DC generation. Eur. J. Immunol. https://doi.org/10.1002/eji.202249816 (2022).
Zanoni, I. et al. An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells. Science 352, 1232–1236 (2016).
Hatter, J. A. et al. Toxoplasma gondii infection triggers chronic cachexia and sustained commensal dysbiosis in mice. PLoS ONE 13, e0204895 (2018).
Kasper, D. C. et al. Quantitative real-time polymerase chain reaction for the accurate detection of Toxoplasma gondii in amniotic fluid. Diagn. Microbiol. Infect. Dis. 63, 10–15 (2009).
Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784 (2014).
Acknowledgements
The authors want to thank the members of Ewald lab for their feedback. We thank Dr. Hervé Agaisse for his insights and suggestions for this manuscript. We thank Dr. André Marette for sharing the Nos2fl/fl mice and for constructive discussion of their use to evaluate iNOS biology in vivo. We also thank Dr. Nicholas E. Sherman and the Biomolecular Analysis Facility Core for LC-MS. This work used TEM sample preparation service in the Advanced Microscopy Facility (Research Resource Identifiers (RRID): SCR_018736). Transmission electron micrographs were recorded at the University of Virginia Molecular Electron Microscopy Core facility (RRID:SCR_019031), which is built with NIH grant G20-RR31199. BAF, AMF, and MEMC are supported by the University of Virginia School of Medicine. This work used Zeiss 980 Confocal system (funded by NIH-OD 025156) in the W.M. Keck Center for Cellular Imaging. M.M.M. is supported by Wagner Fellowship by University of Virgnia. This work is supported by NIGMS R35GM138381 (S.E.E.) and NIAID R21AI156153 (S.E.E.).
Author information
Authors and Affiliations
Contributions
Conceptualization: X.Y.Z., S.L.L., J.U.A., S.E.E.; Research Design: X.Y.Z., S.E.E.; Investigation: X.Y.Z., S.L.L., J.U.A., M.M.M., B.Y., N.K.H.; Data analysis: X.Y.Z., S.L.L.; Image quantification: X.Y.Z., S.L.L., J.S., I.G.B; Manuscript Drafting and Editing: X.Y.Z., S.E.E.; Supervision: S.R., S.E.E.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Communications thanks Laura Knoll, George Yap and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Source data
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhao, XY., Lempke, S.L., Urbán Arroyo, J.C. et al. iNOS is necessary for GBP-mediated T. gondii clearance in murine macrophages via vacuole nitration and intravacuolar network collapse. Nat Commun 15, 2698 (2024). https://doi.org/10.1038/s41467-024-46790-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41467-024-46790-y
- Springer Nature Limited